Esophagitis associated with alendronate sodium.
Pizzani
E
E
Department of Internal Medicine, St. Mary's Hospital, Richmond, Virginia 23226-1927, USA.
Valenzuela
G
G
D000368:Aged; D000369:Aged, 80 and over; D019386:Alendronate / Q000008:administration & dosage / Q000009:adverse effects*; D004941:Esophagitis / Q000139:chemically induced* / Q000175:diagnosis; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000188:drug therapy
D019386:Alendronate